IL326278A - Crystalline form h1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hemihydrate - Google Patents
Crystalline form h1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hemihydrateInfo
- Publication number
- IL326278A IL326278A IL326278A IL32627826A IL326278A IL 326278 A IL326278 A IL 326278A IL 326278 A IL326278 A IL 326278A IL 32627826 A IL32627826 A IL 32627826A IL 326278 A IL326278 A IL 326278A
- Authority
- IL
- Israel
- Prior art keywords
- hemihydrate
- carbonitrile
- piperidin
- quinoline
- trifluoromethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP23190665 | 2023-08-09 | ||
| PCT/EP2024/072511 WO2025032195A1 (en) | 2023-08-09 | 2024-08-08 | Crystalline form h1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hemihydrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326278A true IL326278A (en) | 2026-04-01 |
Family
ID=87567618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326278A IL326278A (en) | 2023-08-09 | 2024-08-08 | Crystalline form h1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hemihydrate |
Country Status (6)
| Country | Link |
|---|---|
| KR (1) | KR20260049276A (en) |
| CN (1) | CN121646584A (en) |
| AU (1) | AU2024319768A1 (en) |
| IL (1) | IL326278A (en) |
| MX (1) | MX2026001248A (en) |
| WO (1) | WO2025032195A1 (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3005766A1 (en) | 2015-12-17 | 2017-06-22 | Merck Patent Gmbh | Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders |
-
2024
- 2024-08-08 CN CN202480051151.1A patent/CN121646584A/en active Pending
- 2024-08-08 AU AU2024319768A patent/AU2024319768A1/en active Pending
- 2024-08-08 WO PCT/EP2024/072511 patent/WO2025032195A1/en active Pending
- 2024-08-08 IL IL326278A patent/IL326278A/en unknown
- 2024-08-08 KR KR1020267007080A patent/KR20260049276A/en active Pending
-
2026
- 2026-01-30 MX MX2026001248A patent/MX2026001248A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN121646584A (en) | 2026-03-10 |
| WO2025032195A1 (en) | 2025-02-13 |
| AU2024319768A1 (en) | 2026-03-26 |
| MX2026001248A (en) | 2026-03-02 |
| KR20260049276A (en) | 2026-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL316075A (en) | Crystalline form of lanifibranor | |
| IL318054A (en) | Crystalline forms of 1,2,4-oxadiazole fungicides | |
| IL326278A (en) | Crystalline form h1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hemihydrate | |
| CA3300783A1 (en) | Crystalline form h1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hemihydrate | |
| IL325727A (en) | Crystalline form | |
| IL326346A (en) | Crystalline form a1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hcl | |
| IL314168A (en) | Crystalline forms of 3-(5-(2-hydroxy-2-methylpropoxy)-6-methylpyrazin-2-yl)-1h-indole-7-carbonitrile | |
| IL326355A (en) | Crystalline form of 5-((3r,5s)-3-amino-5-trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile | |
| CA3300925A1 (en) | Crystalline form a1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hcl | |
| CA3300929A1 (en) | Crystalline form of 5-((3r,5s)-3-amino-5-trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile | |
| IL320718A (en) | Crystalline forms of 5-[(2,4-dinitrophenoxy)methyl]-1-methyl-2-nitro-1h-imidazole | |
| GB202312252D0 (en) | Crystalline compositions | |
| HK40086525A (en) | Process, compositions, and crystalline forms of substituted pyridinone-pyridinyl compounds | |
| CA3271832A1 (en) | Crystalline forms of 5-[(2,4-dinitrophenoxy)methyl]-1-methyl-2-nitro-1h-imidazole | |
| HK40116601A (en) | Crystalline form of lanifibranor | |
| GB202311665D0 (en) | Modification of composition | |
| HK40114513A (en) | Crystalline forms of 3-(5-(2-hydroxy-2-methylpropoxy)-6-methylpyrazin-2-yl)-1h-indole-7-carbonitrile | |
| PH22022050567U1 (en) | Composition of mango-tamarind candy | |
| LT4615820T (en) | Crystalline forms of evenamide | |
| CA3290339A1 (en) | Crystalline forms of 3-(5,7-difluoro-4-oxo-1,4-dihydroquinolin-2-yl)-4-(methylsulfonyl)benzonitrile | |
| CA3269718A1 (en) | Crystalline form of deuruxolitinib | |
| CA3289955A1 (en) | Composition vaccinale anti-ngf | |
| GB202217726D0 (en) | Crystalline compound | |
| GB202510711D0 (en) | Composition | |
| GB202509639D0 (en) | Composition |